Bortezomib as First Salvage Therapy for Myeloma Patients Previously Exposed to Bortezomib as Initial Treatment.

Clinical trial NCT02797041 · UNKNOWN

Trial details

NCT number: NCT02797041
Sponsor: IRCCS Centro di Riferimento Oncologico della Basilicata
Status: UNKNOWN
Study type: OBSERVATIONAL

Multiple Myeloma

Start date: 2015-08-01
Primary completion: 2016-03-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.